However, if two different antigens can be bound simultaneously on the same cell, then cancer cell selectivity may be possible and several immunotherapeutic mechanisms of action, such as growth factor receptor inhibition, neutralization of immune evasion mechanisms, or induction of apoptosis and ADCC (or RDL), can potentially be combined. Here, LEO1 is linked to cancer.